Psoriatic Arthritis Treatment Market to Grow with a CAGR of 5.69% through 2030

Surge in research and development activities is expected to drive the Global Psoriatic Arthritis Treatment Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Psoriatic Arthritis Treatment Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Psoriatic Arthritis Treatment Market stood at USD 9.78 Billion in 2024 and is anticipated to grow with a CAGR of 5.69% through 2030. Initiatives taken by government based on psoriatic arthritis treatment has led to favorable market conditions for the Global Psoriatic Arthritis Treatment Market. Several factors contribute to the growth of various psoriatic arthritis treatment products.

This heightened R&D investment is facilitating the discovery and development of novel drug candidates, including advanced biologics, small molecule inhibitors, and next-generation targeted therapies. Cutting-edge technologies such as genomics, proteomics, and biomarker-driven approaches are being leveraged to develop more precise and effective treatments. Furthermore, the acceleration of clinical trials and regulatory approvals is enabling faster market entry for innovative therapies, expanding the available treatment options for healthcare providers and patients.

Governments worldwide are increasingly recognizing the growing burden of psoriatic arthritis (PsA) and are implementing strategic initiatives to improve patient outcomes and facilitate access to effective treatments. Key measures include enhancing healthcare infrastructure, promoting early diagnosis, and supporting research and development in autoimmune and inflammatory diseases. Collaborations between government bodies, pharmaceutical companies, and research institutions are being fostered to accelerate clinical trials and promote the development of personalized medicine approaches, addressing the heterogeneous nature of PsA.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Psoriatic Arthritis Treatment Market”

The Global Psoriatic Arthritis Treatment Market is segmented into drug class, route of administration, regional distribution, and company.

Based on Drug Class, DMARDs have emerged as the dominating segment in the Global Psoriatic Arthritis Treatment Market in 2024. This is due to their ability to address the underlying causes of the disease rather than just alleviating symptoms. Unlike symptomatic treatments, DMARDs slow disease progression, improve long-term outcomes, and help prevent joint damage, which makes them the preferred choice among healthcare providers and patients. The growing emphasis on early and effective intervention in psoriatic arthritis management has further driven the demand for DMARDs.

Based on Region, Asia Pacific have emerged as the fastest growing region in the Global Psoriatic Arthritis Treatment Market in 2024. This is due to several strategic and demographic factors. Rapid urbanization and economic development have increased healthcare access and affordability, leading to a growing patient pool seeking advanced treatment options. Additionally, rising awareness about psoriatic arthritis among both healthcare professionals and patients has driven early diagnosis and treatment adoption. The expanding healthcare infrastructure, coupled with government initiatives aimed at improving chronic disease management, has further supported market growth.

Major companies operating in Global Psoriatic Arthritis Treatment Market are:

• AbbVie Inc.
• Amgen Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Novartis AG
• Eli Lilly and Company
• Pfizer, Inc.
• UCB S.A.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Nanotechnology is playing an increasingly significant role in the Global Psoriatic Arthritis Treatment Market by offering innovative solutions that enhance drug delivery and therapeutic efficacy. Through the use of nanoparticles and nano-carriers, treatments can be targeted more precisely to affected tissues, improving drug absorption and minimizing systemic side effects. This advancement not only increases the effectiveness of existing therapies but also enables the development of novel treatment modalities that were previously unattainable”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Psoriatic Arthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (NSAIDs, DMARDs, Biologics, Others), By Route of Administration (Topical, Oral, Injectable), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Psoriatic Arthritis Treatment Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Psoriatic Arthritis Treatment Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]